PL369330A1 - Sposób wytwarzania metanosulfonianów pochodnych piperazyny - Google Patents

Sposób wytwarzania metanosulfonianów pochodnych piperazyny

Info

Publication number
PL369330A1
PL369330A1 PL02369330A PL36933002A PL369330A1 PL 369330 A1 PL369330 A1 PL 369330A1 PL 02369330 A PL02369330 A PL 02369330A PL 36933002 A PL36933002 A PL 36933002A PL 369330 A1 PL369330 A1 PL 369330A1
Authority
PL
Poland
Prior art keywords
mesylates
preparation
piperazine derivatives
piperazine
derivatives
Prior art date
Application number
PL02369330A
Other languages
English (en)
Other versions
PL208363B1 (pl
Inventor
Marcel P.M.Van Aar
Stefanus J. Schouten
Jan Zorgdrager
Michiel C. Heslinga
Original Assignee
Solvay Pharmaceuticals B.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharmaceuticals B.V. filed Critical Solvay Pharmaceuticals B.V.
Publication of PL369330A1 publication Critical patent/PL369330A1/pl
Publication of PL208363B1 publication Critical patent/PL208363B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
PL369330A 2001-02-16 2002-02-14 Sposób wytwarzania mezylanów pochodnych piperazyny i mezylany pochodnych piperazyny PL208363B1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP01200534 2001-02-16

Publications (2)

Publication Number Publication Date
PL369330A1 true PL369330A1 (pl) 2005-04-18
PL208363B1 PL208363B1 (pl) 2011-04-29

Family

ID=8179894

Family Applications (1)

Application Number Title Priority Date Filing Date
PL369330A PL208363B1 (pl) 2001-02-16 2002-02-14 Sposób wytwarzania mezylanów pochodnych piperazyny i mezylany pochodnych piperazyny

Country Status (34)

Country Link
US (1) US7030241B2 (pl)
EP (1) EP1362040B1 (pl)
JP (1) JP4328528B2 (pl)
KR (2) KR100859106B1 (pl)
CN (1) CN1176079C (pl)
AR (1) AR034206A1 (pl)
AT (1) ATE284875T1 (pl)
AU (1) AU2002250962B2 (pl)
BG (1) BG66101B1 (pl)
BR (1) BR0205683A (pl)
CA (1) CA2422703C (pl)
CZ (1) CZ301780B6 (pl)
DE (1) DE60202261T2 (pl)
DK (1) DK1362040T3 (pl)
DZ (1) DZ3489A1 (pl)
ES (1) ES2230481T3 (pl)
HR (1) HRP20030610B1 (pl)
HU (1) HUP0400772A3 (pl)
IL (1) IL153509A (pl)
IS (1) IS2417B (pl)
ME (1) MEP37508A (pl)
MX (1) MXPA03002359A (pl)
MY (1) MY130687A (pl)
NO (1) NO324460B1 (pl)
NZ (1) NZ524632A (pl)
PL (1) PL208363B1 (pl)
PT (1) PT1362040E (pl)
RS (1) RS51126B (pl)
RU (1) RU2272036C2 (pl)
SI (1) SI1362040T1 (pl)
SK (1) SK286143B6 (pl)
UA (1) UA75390C2 (pl)
WO (1) WO2002066449A2 (pl)
ZA (1) ZA200301590B (pl)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7435738B2 (en) 2003-08-18 2008-10-14 Solvay Pharmaceuticals, Inc. Stable crystalline form of bifeprunox mesylate (7-[4-([1,1′-biphenyl]-3-ylmethyl)-1-piperazinyl]-2(3H)-benzoxazolone monomethanesulfonate)
AR045362A1 (es) * 2003-08-18 2005-10-26 Solvay Pharm Bv Forma cristalina estable de mesilato de bifeprunox (monometansulfonato de 7-[4-([1,1- bifenil] -3- ilmetil) -1- piperazinil] - 2-(3h) -benzoxazolona
US7405216B2 (en) 2004-08-18 2008-07-29 Solvay Pharmaceuticals, B.V. Stable crystalline form of bifeprunox mesylate (7-[4-([1,1′-biphenyl]-3-ylmethyl)-1-piperazinyl]-2(3H)-benzoxazolone monomethanesulfonate)
US7964604B2 (en) * 2005-02-18 2011-06-21 Solvay Pharmaceuticals B.V. Bifeprunox mesylate maintenance dose compositions and methods for using the same
US7423040B2 (en) * 2005-02-18 2008-09-09 Irene Eijgendaal Stable crystalline form of bifeprunox mesylate, dosage forms thereof and methods for using same
US20070275977A1 (en) * 2006-05-02 2007-11-29 Van Aar Marcel P N-oxides of pyridylmethyl -piperazine and -piperidine derivatives
US8106056B2 (en) 2006-06-16 2012-01-31 Solvay Pharmaceuticals B.V. Combination preparations comprising bifeprunox and a dopamine agonist
US7786126B2 (en) 2006-06-16 2010-08-31 Solvay Pharmaceuticals B.V. Combination preparations comprising SLV308 and a dopamine agonist
US20090068290A1 (en) * 2006-08-31 2009-03-12 Michel Bourin Bifeprunox doses for treating schizophrenia
AU2007291234A1 (en) 2006-08-31 2008-03-06 Solvay Pharmaceuticals B.V. Titration schedule for bifeprunox for treating schizophrenia and kits for use therein
US20080132520A1 (en) * 2006-08-31 2008-06-05 Winsemius Antje A Compositions, kits and methods for administering a titration schedule comprising bifeprunox compounds
CN101939009B (zh) 2008-02-05 2013-07-17 哈博生物科学公司 药学固体形式
WO2011023796A1 (en) 2009-08-31 2011-03-03 Abbott Healthcare Products B.V. Bifeprunox for treating addiction
UY32934A (es) 2009-10-12 2011-05-31 Abbott Healthcare Products Bv Monohidrato de pardoprunox

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0185429A1 (en) * 1984-12-21 1986-06-25 Duphar International Research B.V New bicyclic heteroaryl piperazines
DE3586794T2 (de) 1984-12-21 1993-05-27 Duphar Int Res Arzneimittel mit psychotroper wirkung.
JPH0344383A (ja) * 1989-07-12 1991-02-26 Ihara Chem Ind Co Ltd ５―トリフルオロメチル―２―ハロメチルベンゾチアゾール類の製造法
JP3044383B2 (ja) * 1990-05-22 2000-05-22 コニカ株式会社 含窒素６員環化合物の製造方法
GB9200293D0 (en) * 1992-01-08 1992-02-26 Wyeth John & Brother Ltd Piperazine derivatives
ES2271967T3 (es) * 1996-03-29 2007-04-16 Duphar International Research B.V Compuestos de piperazina y piperidina.
SE9702799D0 (sv) * 1997-07-25 1997-07-25 Astra Ab New compounds
UA71590C2 (en) * 1998-11-13 2004-12-15 Duphar Int Res Piperazine and piperidine derivatives
US7435738B2 (en) 2003-08-18 2008-10-14 Solvay Pharmaceuticals, Inc. Stable crystalline form of bifeprunox mesylate (7-[4-([1,1′-biphenyl]-3-ylmethyl)-1-piperazinyl]-2(3H)-benzoxazolone monomethanesulfonate)

Also Published As

Publication number Publication date
PT1362040E (pt) 2005-05-31
CA2422703C (en) 2010-04-13
DE60202261D1 (de) 2005-01-20
BR0205683A (pt) 2004-07-06
RU2272036C2 (ru) 2006-03-20
HRP20030610B1 (en) 2006-02-28
KR20080064206A (ko) 2008-07-08
US7030241B2 (en) 2006-04-18
HK1059934A1 (en) 2004-07-23
DE60202261T2 (de) 2005-05-19
SI1362040T1 (en) 2005-06-30
CZ301780B6 (cs) 2010-06-23
KR101000733B1 (ko) 2010-12-14
CZ2003697A3 (cs) 2003-06-18
CN1463268A (zh) 2003-12-24
UA75390C2 (en) 2006-04-17
PL208363B1 (pl) 2011-04-29
WO2002066449A3 (en) 2002-10-24
MXPA03002359A (es) 2003-06-30
BG66101B1 (bg) 2011-04-29
NO20031754D0 (no) 2003-04-15
JP2004518741A (ja) 2004-06-24
ZA200301590B (en) 2004-02-05
RS51126B (sr) 2010-10-31
SK3092003A3 (en) 2003-09-11
KR20030077523A (ko) 2003-10-01
US20040077631A1 (en) 2004-04-22
JP4328528B2 (ja) 2009-09-09
HUP0400772A2 (hu) 2004-08-30
IS2417B (is) 2008-10-15
DK1362040T3 (da) 2005-01-24
NO324460B1 (no) 2007-10-22
IL153509A0 (en) 2003-07-06
DZ3489A1 (fr) 2002-08-29
SK286143B6 (sk) 2008-04-07
IS6876A (is) 2003-07-17
EP1362040A2 (en) 2003-11-19
ATE284875T1 (de) 2005-01-15
CN1176079C (zh) 2004-11-17
NZ524632A (en) 2004-03-26
NO20031754L (no) 2003-04-15
HUP0400772A3 (en) 2008-02-28
AU2002250962B2 (en) 2006-08-24
MY130687A (en) 2007-07-31
MEP37508A (en) 2011-02-10
AR034206A1 (es) 2004-02-04
CA2422703A1 (en) 2002-08-29
IL153509A (en) 2007-12-03
WO2002066449A2 (en) 2002-08-29
EP1362040B1 (en) 2004-12-15
HRP20030610A2 (en) 2005-06-30
KR100859106B1 (ko) 2008-09-18
BG108090A (bg) 2004-12-30
ES2230481T3 (es) 2005-05-01
YU64403A (sh) 2006-05-25

Similar Documents

Publication Publication Date Title
HUP0300567A3 (en) Process for preparation of novel piperazine derivatives
HUP0300592A3 (en) Process for the preparation of 2-halobenzoic acid derivatives
HUP0402027A3 (en) Process for the preparation of a xantophyll
HUP0401600A3 (en) Process for the preparation of 14-hydroxymorphine derivatives
IL160043A0 (en) Process for the preparation of indole derivatives
HRP20030610A2 (en) Process for the preparation of mesylates of piperazine derivatives
IL143106A (en) Process for the preparation of diphenylmethylthioacetamide
IL187126A0 (en) Process for the preparation of 4 - haloalkylnicotinonitriles
IL162385A0 (en) Process for the preparation of echinocandin derivatives
AU6744201A (en) Process for the preparation of aniline compounds
IL158360A0 (en) Process for the preparation of 7-substituted 3-alkyl-3h-isobenzofuran-1-one derivatives
IL162188A0 (en) Process for the preparation of Ä1,4,5Ü-oxadiazepine derivatives
AU8824201A (en) Process for the preparation of dinapsoline
HUP0201837A3 (en) Process for preparation n-carboxy-anhydrides
HUP0101875A3 (en) Process for the preparation of piperidine derivatives
IL165137A0 (en) Process for the preparation of thioalkylamine derivatives
IL150897A0 (en) Process for the preparation of acetyl-amidiniophenylalanyl cyclohexylglycyl-pyridinioalaninamides
HUP0303025A3 (en) Process for the preparation of arylethanoldiamines
IL162770A (en) Process for the preparation of 7??-methyl-estr-4-ene-3-one derivatives
IL190807A0 (en) Process for the preparation of 2-aminoethylpyridines
IL164788A0 (en) Process for the preparation of 3-isochromanone
PL368905A1 (pl) Sposób otrzymywania beta-jonylidenoacetaldehydu
HUP0301141A3 (en) Method for the production of trioxime derivatives
GB0012249D0 (en) Process for the preparation of 11-oxaprostaglandins
SI1385850T1 (en) New process for the preparation of oxabispidines